Literature DB >> 10529402

Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts.

M Bond1, A H Baker, A C Newby.   

Abstract

Expression of matrix metalloproteinases (MMPs)-1 and -3 in fibroblasts is upregulated by pro-inflammatory cytokines and growth factors during proliferative inflammatory processes, including wound healing and rheumatoid arthritis. The Activator Protein-1 (AP-1) transcription factor is essential but, we show here, not sufficient for upregulation because platelet derived growth factor (PDGF) and basic fibroblast growth factor (bFGF), which strongly activate AP-1, poorly induce MMP-1 and -3. Interleukin-1alpha, which activates nuclear factor-kappaB (NF-kappaB), synergistically upregulates MMP-1 and -3 expression in the presence of bFGF or PDGF. Adenovirus mediated overexpression of IkappaBalpha, the inhibitor of NF-kappaB, completely suppresses MMP-1 and -3 protein and mRNA expression. Hence, we show for the first time that (NF-kappaB) activity is also essential for MMP-1 and -3 upregulation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529402     DOI: 10.1006/bbrc.1999.1551

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

Review 1.  Role of nuclear factor kappaB in synovial inflammation.

Authors:  Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

2.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium.

Authors:  D M Brantley; C L Chen; R S Muraoka; P B Bushdid; J L Bradberry; F Kittrell; D Medina; L M Matrisian; L D Kerr; F E Yull
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

3.  Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection.

Authors:  Jiehao Zhou; Stephen A Stohlman; Roscoe Atkinson; David R Hinton; Norman W Marten
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

4.  Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.

Authors:  Takashi Miyake; Motokuni Aoki; Mariana K Osako; Munehisa Shimamura; Hironori Nakagami; Ryuichi Morishita
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

5.  Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury.

Authors:  J Xu; G M Kim; S H Ahmed; J Xu; P Yan; X M Xu; C Y Hsu
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

6.  The protective effects of metformin in an in vitro model of aging 3T3 fibroblast under the high glucose conditions.

Authors:  Tugba Soydas; Elif Yaprak Sarac; Suzan Cinar; Sibel Dogan; Seyhun Solakoglu; Matem Tuncdemir; Gonul Kanigur Sultuybek
Journal:  J Physiol Biochem       Date:  2018-03-06       Impact factor: 4.158

7.  Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways.

Authors:  Yi-Cheng Lin; Yu-Chih Liang; Ming-Thau Sheu; Yu-Chen Lin; Ming-Shium Hsieh; Tzeng-Fu Chen; Chien-Ho Chen
Journal:  Rheumatol Int       Date:  2008-03-14       Impact factor: 2.631

8.  Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB.

Authors:  Veronika Souslova; Paul A Townsend; Jelena Mann; Chris M van der Loos; Anna Motterle; Fulvio D'Acquisto; Derek A Mann; Shu Ye
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

9.  Cordycepin inhibits UVB-induced matrix metalloproteinase expression by suppressing the NF-kappaB pathway in human dermal fibroblasts.

Authors:  Young Rae Lee; Eun Mi Noh; Eun Yong Jeong; Seok Kweon Yun; Young Ju Jeong; Jong Hyeon Kim; Kang Beom Kwon; Byeong Soo Kim; Sung Ho Lee; Chang Sik Park; Jong Suk Kim
Journal:  Exp Mol Med       Date:  2009-08-31       Impact factor: 8.718

Review 10.  The immune system and cardiac repair.

Authors:  Nikolaos G Frangogiannis
Journal:  Pharmacol Res       Date:  2008-06-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.